If your child has recently been diagnosed with type 2 diabetes or is at risk, we have the essential information you require. Type 2 diabetes occurs when the body cannot effectively utilize insulin, leading to elevated levels of sugar in the blood. Children and young adults with type 2 diabetes experience a more aggressive form of the condition, but with proper care, it can be effectively managed to prevent complications.
What is type 2 diabetes?
Type 2 diabetes in children and young adults arises from insulin-related issues that result in increased sugar levels. Without proper treatment, it can cause lasting harm due to high blood sugar levels, but with expert help, it can be successfully managed.
What are the symptoms of type 2 diabetes in children?
The symptoms of type 2 diabetes may manifest gradually and include frequent urination, persistent thirst, fatigue, weight loss, itching, delayed wound healing, and blurry vision.
Type 2 diabetes risk factors
Risk factors such as obesity, ethnicity, and family medical history can heighten the chances of type 2 diabetes in children. Making lifestyle adjustments like following a balanced diet and engaging in physical activity are crucial in controlling the condition.
Will it go away?
Type 2 diabetes is not curable, but some individuals can achieve a state of remission by shedding excess weight. While there is limited evidence on remission in children and young individuals, ongoing research is dedicated to this area.
Complications
Youth with type 2 diabetes are at a heightened risk of complications compared to adults. Heart disease, kidney damage, and issues with the eyes or nerves can progress more rapidly in younger patients.
Will they need medication?
Common treatments prescribed for children with type 2 diabetes include Metformin and insulin. Specialized pediatric diabetes clinics offer invaluable assistance, although the availability of such clinics may vary.
Checking blood sugar levels
Healthcare professionals will provide guidance on managing blood sugar levels and hypoglycemia in children with type 2 diabetes. Continuous glucose monitors may be recommended for those susceptible to hypoglycemia.
Looking after your emotional health
It is imperative for caregivers to prioritize self-care while tending to a child with diabetes. Supporting your child’s mental well-being by addressing any emotional difficulties they may encounter is crucial.
Who should I tell?
Notify your child’s school about their type 2 diabetes diagnosis to ensure they receive the necessary support with their dietary needs, physical activity, and insulin administration.
Prevention
Research indicates that lifestyle modifications can aid in preventing type 2 diabetes in children and adults, focusing on a well-rounded diet and engaging in physical activities that involve the entire family.
Diet
The importance of healthy eating in managing type 2 diabetes cannot be overstated. Explore our meal plans and resources for guidance on making nutritious choices.
What’s next?
For additional advice or support, reach out to our helpline or seek guidance from others living with diabetes on our forum.
If you’re a young adult diagnosed with type 2 diabetes or at risk, visit our page for further details.
Received 2013 Dec 3; Revised 2014 Mar 5; Accepted 2014 Apr 9; Issue date 2014 Jun 15.
Additional Information
In addition to the factors mentioned in the review, it is important to note that regular physical activity and a healthy diet play a significant role in the prolonged survival of individuals with type 1 diabetes. Exercise helps in maintaining cardiovascular health, improving insulin sensitivity, and reducing the risk of developing complications such as coronary artery disease.
Furthermore, staying up to date with regular medical check-ups, including monitoring blood sugar levels, cholesterol levels, and blood pressure, is crucial for managing diabetes and reducing the risk of cardiovascular events. It is also essential for individuals with type 1 diabetes to work closely with healthcare providers to develop a personalized treatment plan that addresses their specific needs and concerns.
Overall, a holistic approach to diabetes management, including a focus on lifestyle factors, regular medical care, and adherence to treatment recommendations, can greatly improve the prognosis and longevity of individuals with type 1 diabetes.
INTRODUCTION
Prior to the discovery of insulin, patients with type 1 diabetes had a life expectancy of under 3 years. With modern treatment regimens, survival rates have improved. However, individuals with type 1 diabetes still experience higher rates of coronary artery disease (CAD) incidence and mortality compared to the general population. Mortality rates among patients with type 1 diabetes under 60 years of age were notably higher than in the general population. Women with diabetes faced higher mortality rates than women without diabetes or men without diabetes. The risk of developing cardiovascular disease remains elevated in individuals with type 1 diabetes, with these patients reaching the risk of fatal CVD earlier than the general population. Incidences of CAD and stroke are more prevalent in individuals with type 1 diabetes compared to the general population.
Figure 1.
A comparison of mortality rates from ischemic heart disease between patients with type 1 diabetes and the general population.
Despite advancements in treatment, individuals with type 1 diabetes still tend to have a reduced life span due to CVD. Nonetheless, a subgroup of these patients manages to live into old age in good health. This review delves into the factors that help identify these long-term survivors.
THE ROLE OF GLYCAEMIC CONTROL
Type 1 diabetes primarily manifests as hyperglycemia. While the connection between hyperglycemia and CVD is acknowledged, optimum glucose control alone does not clarify why certain patients avoid fatal CVD events. An elderly cohort of patients with type 1 diabetes who have survived for an extended period showed moderate HbA1c levels. Studies propose a weak correlation between glycemic control and mortality. Timely glycemic control is crucial for preventing CVD. Findings suggest that the importance of good glycemic control may diminish over time.
Figure 2.
The correlation between overall mortality and glycemic control.
While effective glycemic control is vital for survival, its significance may decrease over time. Glycemic control alone does not solely govern survival rates in patients with type 1 diabetes.
Further research is needed to explore other factors that may contribute to the survival of type 1 diabetes patients, beyond glycemic control. Factors such as lifestyle choices, genetic predisposition, and the presence of other comorbidities may play a significant role in determining outcomes. Understanding the complex interplay of these factors can help healthcare providers tailor treatment plans to optimize outcomes for patients with type 1 diabetes.
LIPIDS IN TYPE 1 DIABETES
Patients with type 1 diabetes may exhibit lipid disorders related to glycemic control that impact cardiovascular results. Well-regulated diabetes showcases distinct lipid profiles compared to poorly controlled cases due to the effects of insulin. Hyperinsulinemia influences triglyceride and LDL-cholesterol levels, with increased sensitivity to insulin intensifying these effects. Elevated LDL-cholesterol and non-HDL-cholesterol levels are associated with arterial stiffness, CAD, and mortality. Higher levels of HDL-cholesterol are linked to extended life spans and protection against CVD. HDL-cholesterol plays a significant role in decreasing CVD risk in patients with type 1 diabetes. Hypertension in type 1 diabetes might be linked to nephropathy or exist independently. High blood pressure is connected to arterial stiffness, but treating hypertension does not impact longevity in these individuals. Diabetic nephropathy heightens the risk of CAD, cardiovascular mortality, and all-cause mortality. Albuminuria is strongly correlated with CAD and stroke risk in type 1 diabetes. Enhancing glycemic control offers long-term benefits in reducing albumin excretion and preserving kidney function. Nephropathy typically peaks 15-20 years after the onset of diabetes and gradually decreases over time. Survi. . .
Figure 3.
A substantial increase in Intima-Media Thickness is noted in patients with Metabolic Syndrome (MetS).
GENETIC FACTORS
The family history has a role in predicting longevity in patients with type 1 diabetes. Individuals with a family history of long life or specific conditions such as type 2 diabetes tend to have increased Intima-Media Thickness. Identifying patients who survive long-term can be achieved by examining factors like glycemic control, levels of HDL-cholesterol, insulin requirements, body weight, and blood pressure.
Figure 4.
Various factors interact to determine outcomes for patients with type 1 diabetes. These intricate interactions play a part in the risks of cardiovascular disease (CVD).
Table 2.
Characteristics that are common among individuals with type 1 diabetes who live long lives include: maintaining stable blood sugar levels, having high levels of HDL-cholesterol, requiring low amounts of insulin, maintaining a normal body weight, being non-smokers, having lower blood pressure, and showing no signs of microalbumin after several years of having diabetes. Additionally, having a family history of longevity can also play a role.
CONCLUSION
Although life expectancy for individuals with type 1 diabetes has increased, there are some who defy the odds and live even longer. By looking at clinical and biochemical factors, these patients can be identified. It is essential to manage factors that can be changed in order to ensure their continued longevity.
Regular exercise, maintaining a healthy diet, monitoring blood sugar levels, and taking medication as prescribed are all important factors in managing type 1 diabetes and promoting longevity. Additionally, regular check-ups with healthcare providers and staying informed about new treatments and technologies can also play a significant role in ensuring a longer and healthier life for those living with type 1 diabetes.
ACKNOWLEDGMENTS
The contribution of individuals like Michael Brown is invaluable in the process of editing and preparing manuscripts.
Footnotes
The role of reviewers and editors is crucial in the process of publishing.
Reviewers play a key role in evaluating the quality of submissions and providing feedback to authors to improve their work. They help ensure that published research meets high standards of academic integrity and contributes to the body of knowledge in the field.
Editors, on the other hand, oversee the entire publication process, from initial submission to final publication. They make decisions on which submissions to accept or reject, coordinate peer review, and ensure that published articles adhere to the journal’s guidelines and standards.
References
- Exploring the history of type 1 diabetes
- Examining mortality rates in diabetes patients
- Investigating heart disease mortality in those with insulin-treated diabetes
- Assessing the risk of cardiovascular disease in type 1 diabetic patients
- Identifying risk factors for coronary heart disease in type 1 diabetic patients
- Understanding the connection between type 1 diabetes and stroke risk
- Examining risk factors for mortality in long-term type 1 diabetic patients
- Studying the impact of intensive diabetes treatment on cardiovascular disease
- Researching the relationship between intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes patients
- Describing the characteristics of type 1 diabetes patients who have lived over 50 years
- Investigating silent coronary atheromatosis in type 1 diabetes patients
- Looking at family histories that may predict intima-media thickness in type 1 diabetes patients
- Examining carotid artery intima-media complex thickening in type 1 diabetes patients
- Studying the connection between glycosylated hemoglobin and cardiovascular disease in diabetes
- Investigating abnormal lipid profiles and the development of microalbuminuria in adolescents with type 1 diabetes